MDCX logo

MDCXMedicus Pharma Ltd

$0.33
$0.014
(4.02%)
Today
Closed $0.3343
$0.0043
(1.29%)
After Hours
Updated: 05:55 PM EDT
Reported EarningsMay 14
Mkt Cap$19.73M
Vol1.6M
News
all
press releases
Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook
Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook...
Yahoo! Finance: News
News Placeholder
More News
News Placeholder
EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline
Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026.read more...
Benzinga
News Placeholder
EXCLUSIVE: Medicus Pharma Refines Trial Design To Cut Costs, Accelerate Development For Enlarged Prostate Patients
Medicus Pharma submits Phase 2 design for Teverelix, targeting faster data readouts and lower costs in benign prostatic hyperplasiaread more...
Benzinga
News Placeholder
Power Hour Surge: Biotech Cash Floods, Energy Breakouts, and AI Bets Drive the Stocks to Watch into the Close
As Wall Street heads into the final stretch of the trading day, capital flows into biotech financing, clean energy, and emerging technology platforms are shaping the stocks traders are watching most closely into the close and after-hours session. $EONR, $SAFX, $KBLB, $HIMS, $MDCX, $ANTX, $NVO, $MDCX, $RLMD, $SLDB, $ANTX, $EDIT, $DDD
24-7 Market News
News Placeholder
Dow Falls Over 300 Points; Kroger Posts Mixed Results
US stocks down, Dow falls 300 points. Dow traded at 48,411.44, NASDAQ at 22,741.80, S&P 500 at 6,847.63. Energy shares rise, healthcare stocks dip. Kroger posts mixed results. Equities up for Impact...
Benzinga
News Placeholder
Medicus Pharma Stock Swings After Skin Cancer Treatment Results
Medicus Pharma stock surged then slipped after the Phase 2 trial showed a 73% clearance rate for its skin cancer treatment.read more...
Benzinga
<
...
1
>